These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38326326)
21. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches. Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149 [TBL] [Abstract][Full Text] [Related]
22. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
23. Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival. Kattan SW; Hobani YH; Shaheen S; Mokhtar SH; Hussein MH; Toraih EA; Fawzy MS; Abdalla HA Cell Mol Biol Lett; 2021 Apr; 26(1):14. PubMed ID: 33849428 [TBL] [Abstract][Full Text] [Related]
24. Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion. Zhang LL; Zhang LF; Guo XH; Zhang DZ; Yang F; Fan YY DNA Cell Biol; 2018 Jan; 37(1):46-52. PubMed ID: 29215918 [TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis. Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901 [TBL] [Abstract][Full Text] [Related]
26. Long Noncoding RNA TTC39A-AS1 Promotes Breast Cancer Tumorigenicity by Sponging MicroRNA-483-3p and Thereby Upregulating MTA2. Zhou Z; Yang P; Zhang B; Yao M; Jia Y; Li N; Liu H; Bai H; Gong X Pharmacology; 2021; 106(11-12):573-587. PubMed ID: 34488224 [TBL] [Abstract][Full Text] [Related]
27. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C. Pan W; Chen KJ; Huang YC Anticancer Drugs; 2022 Oct; 33(9):913-922. PubMed ID: 36136991 [TBL] [Abstract][Full Text] [Related]
28. NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641. Zhong Y; Zeng W J Healthc Eng; 2022; 2022():6778199. PubMed ID: 35083026 [TBL] [Abstract][Full Text] [Related]
29. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway. Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116 [TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA NNT-AS1 functions as an oncogene in breast cancer via repressing ZFP36 expression. Pan QH; Fan YH; Wang YZ; Li DM; Hu CE; Li RX J Biol Regul Homeost Agents; 2020; 34(3):795-805. PubMed ID: 32691576 [TBL] [Abstract][Full Text] [Related]
31. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling. Vishnubalaji R; Alajez NM Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372 [TBL] [Abstract][Full Text] [Related]
32. LncRNA B4GALT1-AS1 promotes non-small cell lung cancer cell growth via increasing ZEB1 level by sponging miR-144-3p. Liu SW; Yang P; Li FN; Dou RG; Liu JX; Liu GJ Transl Cancer Res; 2022 Mar; 11(3):538-547. PubMed ID: 35402178 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD. Luo D; Liang Y; Wang Y; Ye F; Jin Y; Li Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Jiang L; Yang Q Breast Cancer Res; 2023 Sep; 25(1):109. PubMed ID: 37770991 [TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA SOX21-AS1 enhances the stemness of breast cancer cells via the Hippo pathway. Li L; Meng D; Wang R FEBS Open Bio; 2021 Jan; 11(1):251-264. PubMed ID: 33103351 [TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway. Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011 [TBL] [Abstract][Full Text] [Related]
36. lncRNA NUTM2A-AS1 Targets the SRSF1/Trim37 Signaling Pathway to Promote the Proliferation and Invasion of Breast Cancer. Ning X; Zhao J; He F; Yuan Y; Li B; Ruan J Comput Math Methods Med; 2022; 2022():3299336. PubMed ID: 35959349 [TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316 [TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis. Rui X; Xu Y; Jiang X; Ye W; Huang Y; Jiang J Cell Death Dis; 2018 Dec; 9(12):1175. PubMed ID: 30518760 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of long non-coding RNA ZEB2-AS1 and EMT-related markers in ductal and lobular breast cancer. Zarei M; Malekzadeh K; Omidi M; Mousavi P Cancer Rep (Hoboken); 2023 May; 6(5):e1826. PubMed ID: 37088469 [TBL] [Abstract][Full Text] [Related]
40. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]